Endowed Research Chairs

Dr. Jane Schulz

Alberta Women's Health Foundation Endowed Research Chair
Women and Children's Health Research Institute

The University of Alberta Faculty of Medicine & Dentistry is pleased to announce the appointment of Dr. Jane Schulz as Chair of the Department of Obstetrics and Gynecology and the Alberta Women’s Health Foundation endowed research chair for a five-year term, commencing September 1, 2021. The endowed chair is supported through a generous gift from the Alberta Women's Health Foundation through the Women and Children’s Health Research Institute.

Dr. Schulz is a professor in the Department of Obstetrics and Gynecology and has served as the interim chair since July 2019.

During her time as interim chair, she supported a successful residency accreditation, navigated the department through changes and challenges related to COVID-19, and created a bridge strategic plan for women’s health.

Dr. Schulz graduated with honours in research from the U of A’s Faculty of Medicine & Dentistry in 1992. She completed her obstetrics and gynecology residency at the U of A, after which she obtained a McLaughlin scholarship and completed a two-year urogynecology fellowship at the University of London, England, and the University of Toronto. In 1999, she accepted an academic position in the Department of Obstetrics and Gynecology at the U of A, and joined the urogynecology unit at the Royal Alexandra Hospital.

Dr. Schulz is part of a large multidisciplinary clinical academic practice at the Lois Hole Hospital for Women, in addition to being involved in ongoing teaching of medical students, residents, fellows, physicians in the community, and allied health professionals. She served as the academic and clinical division lead for urogynecology from 2009-2019. Other key roles have included coordination of the student internship program at the Royal Alexandra Hospital, running the department CaRMS process for almost a decade, serving as resident research director from 2001-2016 with initiation of the Clinical Investigator Program in the department, and as a member of the health research ethics board biomedical panel.

Dr. Schulz’s research focus is on clinical innovation, quality improvement and projects that have immediate clinical knowledge translation. She is a founding member of the Lois Hole Hospital Women’s Society and the Canadian Society for Pelvic Medicine. Dr. Schulz is an active member of the Women and Children’s Health Research Institute and a women's health research ambassador for the Alberta Women’s Health Foundation. In addition, she has served as the North American representative to the International Committee of the International Urogynecology Association (IUGA), and currently serves on the IUGA publications committee.

The Faculty thanks the search and selection committee who helped make this appointment possible.


Dr. Sue Ross

Cavarzan Chair in Women’s Health Research
Lois Hole Hospital for Women

Since 2012, Dr. Sue Ross has been at the helm of the Cavarzan Chair in Women’s Health Research. Working in collaboration with a multidisciplinary team, she leads a Canada-wide research mandate in the management of menopausal symptoms, pelvic floor disorders and pelvic organ prolapse. With the increase of an aging population in Canada's near future, there is a growing demand for translational solutions for this demographic.

Dr. Ross's focus is on improving the patient experience, and she seeks to ensure the safety and efficacy of treatments available to mature women. Thus far, Dr. Ross has led various clinical trials for the treatment of pelvic floor disorders. She is now focused on determining the prevalence and impact of such disorders using national data obtained by family physicians from across Canada. Dr. Ross also works with local menopause clinics to expand upon the factors that contribute to mature women's wellness, including a measure of their quality of life and of the impact of menopause on their lives.

By increasing the type and quality of treatment options available to mature women, Dr. Ross hopes to empower women to select treatments best suited to their particular physical, emotional and psychological needs. Although writing and research are at the fore for this Chair, Dr. Ross cites her everyday interactions with patients and clinicians at the Lois Hole Hospital for Women as being an instrumental to her research success.


Dr. Cheng-Han Lee

Sawin-Baldwin Chair in Ovarian Cancer
Alberta Cancer Foundation
Alberta Women's Health Foundation

The Faculty of Medicine & Dentistry is pleased to announce the appointment of Dr. Cheng-Han Lee as the Sawin-Baldwin Chair in Ovarian Cancer. The endowed chair is supported through a generous gift from the Alberta Cancer Foundation and the Alberta Women's Health Foundation.

Dr. Lee received his MD/PhD in 2004 from the University of British Columbia, where he also went on to complete his anatomic pathology residency training in 2009. An interest in cancer genetics then led him to pursue a cancer research fellowship focusing on ovarian and uterine cancer at Stanford University Medical Center.

Dr. Lee continued his study of cancer genetics and biology at Brigham and Women’s Hospital in Boston, where he examined the genetic basis and biology of aggressive gynecologic cancer. His work on uterine cancer led to the recognition of a new cancer type that was subsequently adopted in the World Health Organization (WHO) classification system for tumours of the female reproductive system. The focus of his research over the past decade has been on the genetics and biology of aggressive gynecologic cancer.

Dr. Lee currently has more than 130 peer-reviewed publications and a number of book chapters, including the latest WHO classification of female genital tumours. He also served as the program medical director for the Department of Pathology and Laboratory Medicine at B.C. Cancer from 2017 to 2021.

Dr. Lee is expected to join the Faculty in June. In his role as the Sawin-Baldwin Chair in Ovarian Cancer, he will work with a multidisciplinary research team including scientists, surgeons, oncologists and pathologists across different centres in Alberta, British Columbia and Ontario, focusing on gynecologic cancers that are most aggressive and most in need of therapeutic advancement. He will also be on staff and act as a consultant pathologist with a diagnostic focus on gynecologic cancer at the Royal Alexandra Hospital. Dr. Lee will also be supported by the Women and Children's Health Research Institute and the Cancer Research Institute of Northern Alberta and will be a member of both institutes.

The Faculty thanks the selection committee for the time invested to make this appointment possible, and the Alberta Cancer Foundation and the Alberta Women’s Health Foundation for their generous support of ovarian cancer research at the U of A.